Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

(Bloomberg) -- Roche Holding AG will add manufacturing ... The Swiss company will manufacture more diagnostic products in ...

Roche Holdings said it received Food and Drug Administration approval for its companion diagnostic of gastric and gastroesophageal junction cancer. The diagnostic, called the Ventana CLDN18 (43 ...

Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...

Presented at the Clinical Trials in Alzheimer’s Disease congress, being held in Madrid, Spain, Roche’s diagnostics unit showed that a negative result from one test—its Elecsys amyloid plasma ...

In the event of a pandemic situation with a much faster spread of the virus, Roche would require six to nine months to boost diagnostic production further, the CEO added. The World Health ...

On November 8, 2024, Roche Diagnostics enhanced the ... the commercialization of IVD products, and accelerating companion diagnostics cooperation. Pudong New Area has established an innovative ...